BIIB
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FBIIB.O%2Fkey-developments%2Farticle%2F2742217&ei=knKaUpCMFoqw0AGZAw&usg=AFQjCNF--VEol2j6Ditw4Kso5TSEK2munQ
Biogen Idec Inc Raises FY 2013 Guidance
Thursday, 25 Apr 2013 06:30am EDT
Biogen Idec Inc updated its fiscal 2013 financial guidance. For fiscal 2013, the Company expects revenue growth to be approximately 16% to 18%, non-GAAP diluted EPS to be between $7.80 and $7.90 and GAAP diluted EPS to be between $6.69 and $6.79. The Company reported revenues of $5.5 billion in fiscal 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $6.4 billion and EPS of $7.81 for fiscal 2013.Â 
